Proposed divestiture of BioPharma Solutions (BPS) further streamlines Baxter’s strategic focus and represents an important milestone in its ongoing business transformation
Chronic Kidney Disease is a growing epidemic with 850 million people affected worldwide.
It accelerates the company’s vision for transforming healthcare and advancing patient care worldwide – from the hospital to the home
The company shall be engaged in the business of manufacturing of pharmaceutical, bio-pharmaceutical and biological products of any kind
A special purpose vehicle (SPV) formed by O2 Energy SG Pte Ltd, for generation and supply of renewable power
Company hires life science veteran Jessica Cao to join management team
If approved, PreHevbri will be the only approved 3-antigen hepatitis B vaccine for adults in the E.U.
John served as General Manager for Catalent Pharma Solutions in St. Petersburg, Florida
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)